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Abstract 
 
In clinical research, repositories of biological samples form a rich source of clinical material 
for biomarker studies. Banked material however, is often not stored in optimal conditions 
regarding the technology used for biomarker research. A case in point is formalin-fixed 
paraffin-embedded (FFPE) tissue that could be used to obtain large cohorts of samples over a 
short period of time, as these tissues are routinely prepared for pathological analysis. 
However, in the context of mass spectrometry based peptide-centric proteomics, protein 
extraction and identification can be hampered by formalin-induced crosslinking. Furthermore, 
the molecular formalin crosslinks might be entangled differently across various samples, 
making it more difficult to reproducibly extract the same proteins from different samples. In 
this study, we establish the crosslink variability using Tandem Mass Tag (TMT) protein 
labeling followed by protein digestion, separation, identification and quantification of proteins 
extracted from FFPE colorectal cancer and paired healthy tissues. Moreover, by applying de 
novo interpretation of tandem mass spectra and subsequent analysis by Peaks PTM, 
unspecified modifications could be elucidated, leading to increased protein and proteome 
coverage. This approach might be useful for future FFPE proteomics studies.  
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Introduction 
 
In clinical research, fresh sample material, such as, e.g., tissues are often banked for future 
investigation by emerging technologies. These repositories of residual clinical specimens (e.g. 
biobanks, tumorbanks, and pathology archives) are of tremendous interest for biomarker 
discovery research, as they form a rich source of clinical material. The advantage of using 
banked sample material is that pathological, clinical and outcome information exists in these 
collections of tissues 1, which allows for retrospective biomarker research. A disadvantage of 
using banked sample material is that the sample is often not stored in optimal conditions 
regarding the technology used for the biomarker research. A case in point is formalin-fixed 
paraffin-embedded (FFPE) tissue that could be used to obtain large cohorts of samples over a 
short period of time, as these tissues are routinely prepared for pathological analysis 2. 
Moreover, it is the standard method for long-term preservation of clinical specimens. 
Although often denied in biomarker studies, these millions of archived FFPE tissues represent 
thus an unexploited treasure of samples3.  
The proteomic analysis of FFPE tissue often employs technologies, such as Liquid 
Chromatography (LC) and Mass Spectrometry (MS), which are considered as important tools 
in protein biomarker research. Therefore, a substantial need exists to develop methods and 
procedures for this technology to discover new protein biomarker candidates with diagnostic 
or therapeutic potential. However, fixation of tissue samples by formalin leads to extensive 
inter- and intramolecular crosslinking among proteins in these tissues, which hampers the 
proteome analysis of these samples. Due to these crosslinks, not only protein extraction is a 
major challenge, also protein identification might be hindered, as the reaction of proteins with 
formaldehyde will deliver both known and unknown modifications. Moreover, a small 
percentage of the formaldehyde-reactive amino acids e.g. arginine, histidine, cysteine and 
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lysine residues will form irreversible crosslinks, which might be difficult to assess by mass 
spectrometry 4. So far, it is clear that this event of crosslinking is not completely understood 
yet.  
To date, several research groups have demonstrated that protein extraction from FFPE tissue 
sections is feasible using heat-induced antigen retrieval and specialized extraction buffers 
combined with downstream gel-based or gel-free designs 5-8. To quantify FFPE extracted 
proteins, label-free approaches are mostly applied 9, 10. However, in this manuscript, we adopt 
an approach that uses labels. Because up to eight samples are pooled together and processed 
simultaneously by LC and MS, they are affected by the same amount of instrument 
variability, which facilitates a rigorous comparison. Quantification through chemical labeling 
with isobaric tags for relative and absolute quantification (iTRAQ) has been used before in 
the context of FFPE tissue proteomics 11, 12.  However, in this study, we will use Tandem 
Mass Tags (TMT) for quantification purposes and apply a combination of TMT protein 
labeling and 1D electrophoresis combined with LC-MS/MS (= GeLC-MS/MS). Performing 
gel electrophoresis is advantageous in formalin crosslinked protein samples, as not only the 
complex sample is fractionated, also the excess of paraffin and other MS-incompatible buffer 
reagents are removed. Labeling proteins instead of peptides is beneficial in a GeLC-MS/MS 
approach, as in this way, we exclude the circuitous labeling of several in-gel digested peptide 
fractions.  
To our knowledge, this is the first report which performs a quantitative proteome analysis  
using TMT protein labeling in combination with FFPE tissues.  
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Materials and Methods 
 
Human FFPE tissue samples 
Human clinical tissues from patients with colorectal cancer were obtained from biopsies and 
resected tumor material at the university hospital of Leuven. These samples were collected 
under informed consent of all patients and were approved by the local ethical committee. Both 
tumor tissue and adjacent control colon mucosa from surgical resection specimens were 
collected. Diagnosis of colorectal cancer was made as defined by the criteria of the WHO 
classification. The surgical resection specimens were fixed in 6% formalin for 24 to 48 hrs 
and dehydrated before impregnation by paraffin. Afterwards, the FFPE samples were stored at 
room temperature. None of the samples were stored for longer than one month. More 
information about the paired colon mucosa samples is summarized in Table 1. 
Protein extraction 
Per sample, ten slices of 10 µm FFPE sections were collected in a Lobind Eppendorf tube. 
The FFPE samples were deparaffinised in xylene for 10 min, followed by centrifugation at 
10,000 g for 3 min. The tissue pellets were then rehydrated with a graded series of ethanol 
(100%, 95% and 70%). To extract the proteins used for TMT labeling, three paired control 
mucosa and colorectal cancer mucosa FFPE samples were suspended in 20mM Tris HCl pH 
8,8, 200mM DTT, 2% SDS and 1% protease inhibitor (Complete cocktail, Roche, Penzberg, 
Germany) and incubated for 20 min at 98°C, followed by an incubation at 80°C for 2 hrs. 
After centrifugation of the samples at 14,000 g, for 30 min at 4°C, the supernatant was 
transferred to a new tube and stored at -80°C until further use. 
TMT protein labeling 
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All products in this section are supplied with the TMT labeling kit ((Pierce, Thermo 
Scientific, Waltham, MA) unless stated differently. In order to achieve optimal labeling 
conditions, the samples were transferred into 30 kDa centrifugal filter units (Amicon Ultra, 
30K, Millipore, Billerica, MA). After centrifugation at 13 000 g for 10 min, the proteins were 
resuspended in 100 µl of 200 mM triethylammoniumbicarbonate (TEAB)  (pH 8,0). Next, the 
samples were transferred into a mini dialysis tube (cut-off 1kDa, GE Healthcare, Uppsala, 
Sweden) and dialysed for 2 hrs at 4°C. Afterwards, the protein concentration was determined 
using the Qubit method (Invitrogen, Carlsbad , CA). 
Before labeling the proteins, 2x 10 µg proteins of each sample were reduced using 2 µl of    
50 mM tris(2-carboxyethyl) phosphine in a volume of 100 µl 100 mM TEAB , and incubated 
for 1 h at 55°C. Next, the samples were alkylated with 0,5 µl of a 375 mM iodoacetamide 
solution for 30 min at ambient temperature in the dark. For the reconstitution of the tags, the 
TMT labels were dissolved in 41 µl acetonitrile according to the manufacturer’s protocol. 
Subsequently, proteins were labelled with the TMT reagents as follows: the control colon 
mucosa samples were labeled with TMT 126, TMT 128 and TMT 130 and the paired colon 
tumor samples with TMT 127, TMT 129 and TMT 131. From every sample, 10 µg was 
labeled with 4,1 µl of a TMT tag dissolved in acetonitrile. The labeling reaction was stopped 
by adding 5 µl 5% hydroxylamine. After 15 minutes, a pooled sample was prepared based on 
the labeled samples with a protein concentration ratio of 1:1:1:1:1:1. 
1D electrophoresis and trypsin digestion 
The proteins in the mixture were separated by 1D SDS-PAGE using NuPAGE Novex 4-12% 
Bis-Tris precast gel according to the manufacturer’s protocol (Invitrogen, Carlsbad, CA). In 
each lane, 20 µg of proteins were loaded and SeeBlue 2 Plus (Invitrogen) was used as a pre-
stained standard. The gel was stained with Coomassie Brilliant Blue (SimplyBlue SafeStain, 
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Invitrogen) according to the manufacturer’s instructions. Subsequently, a lane was subdivided 
in three parts in order to pre-fractionate the sample. To destain the gel pieces, they were 
suspended in a mixture of 50% acetonitrile and 50% 50 mM ammonium bicarbonate for 30 
min at 37°C. Afterwards, the gel pieces were hydrated with MilliQ, followed by rehydration 
in 100% acetonitrile and then dried in the speedvac concentrator. Next, trypsin (Promega, 
Fitchburg, WI), dissolved in 50 mM ammonium bicarbonate and 5 mM calciumchloride, was 
added at an enzyme to protein ratio of 1:20 and the sample was incubated overnight at 37°C. 
The next day, the tryptic peptides were extracted using 50 mM ammonium bicarbonate 
followed by an extraction with 50% acetonitrile and 1% formic acid. The pooled extracts were 
vacuum dried and the peptides were stored at -20°C. Prior to mass spectrometric analysis, the 
samples were desalted and concentrated using C18 ZipTips (Millipore, Billerica, MA) 
according to the manufacturer’s instructions. The eluted peptides were vacuum dried and 
stored at -80°C until further analysis.  
Nano reverse phase liquid chromatography and mass spectrometry 
The peptide mixture was separated by reverse phase chromatography on an Eksigent nano-
UPLC system using a Pepmap100 C18 precolumn (200µm x 20mm, 5µm particle size) 
coupled to an acclaim C18 column (75µm x 15cm, 3µm particle size) (Thermo Scientific, San 
Jose, CA). Before loading, the sample was dissolved in mobile phase A, containing 2% 
acetonitrile and 0,1% formic acid and spiked with 20 fmol Glu-1-fibrinopeptide B (Glu-fib, 
Protea biosciences, Morgantown, WV). A linear gradient of mobile phase B (0,1% formic 
acid in 98% acetonitrile) in mobile phase A (0,1% formic acid in 2% acetonitrile) from 2 to 
40% in 50 min followed by a steep increase to 95% mobile phase B in 2 min was used at a 
flow rate of 350 nl/min. The nano-LC was coupled online with the mass spectrometer using 
the Triversa NanoMate (Advion, Ithaca, NY) with LC-coupler. 
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The LTQ Orbitrap Velos (Thermo Scientific, San Jose, CA) was set up in a MS/MS mode 
where a full scan spectrum (350 – 5000 m/z , resolution 60 000) was followed by a maximum 
of five dual CID/HCD tandem mass spectra (100 to 2000 m/z). Peptide ions were selected for 
further interrogation by tandem MS as the five most intense peaks of a full scan mass 
spectrum. Collision induced dissociation (CID) scans were acquired in the linear ion trap of 
the mass spectrometer, High Energy collision activated dissociation (HCD) scans in the 
orbitrap, at a resolution of 7500. The normalized collision energy used was 35% in CID and 
55% in HCD. We applied a dynamic exclusion list of 30 sec for data dependent acquisition. 
Data analysis 
Proteome discoverer (1.3) software (Thermo Scientific, San Jose, CA) was used to perform 
database searching against the IPI Human 3.87 database using both Sequest and Mascot 
algorithms, and following settings: precursor mass tolerance of 10 ppm, fragment mass 
tolerance of 0.8 Da. Trypsin was specified as digesting enzyme and 2 miscleavages are 
allowed. Regarding fixed or variable modification settings, carbamidomethylation at 
methionine was always set as fixed modification, and TMT-sixplex labels at N-terminus and 
lysine residues, in combination with methionine oxidation were variable modifications. 
Several extra prespecified modifications e.g. methylation, acetylation,... were also applied in 
order to gain better results. Only medium and high confident peptides with a global FDR at < 
0,05 were included in the results. A summary of these settings and their respective FDR 
values is given in Table 2. 
Peaks studio software (Version 6, Bioinformatics solutions Inc., Waterloo, ON, Canada) was 
also used to analyse the MS/MS spectra for unexpected modifications. Data were refined in 
precursor mass and four different analysis steps were used for protein identification. The 
following analysis steps were comprised in the procedure: de novo interpretation of peptides, 
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Peaks DB search for database driven peptide identification, Peaks PTM search for detecting 
frequently occurring post-translational modifications and the spider search module to align the 
de novo identification on the database.  
All MS/MS spectra were searched using Peaks DB against the IPI human 3.87 database. The 
search parameters were as follows: precursor mass tolerance of 5 ppm, fragment tolerance of 
0,5 Da. Trypsin was selected as digestion enzyme, and 3 missed cleavages were allowed. 
Furthermore, carbamidomethylation (+57,021 Da, C) was set as fixed modification, TMT 6-
plex (+229,163 Da, at N-terminus and K) and oxidation (+ 15,995 Da, M) were dynamic or  
equivalently, variable modifications. We applied a peptide identification filter at FDR<5% 
and protein identification was based on at least one unique peptide. 
The quantitative analysis was conducted by the Peaks software to retrieve information on the 
TMT 6-plex reporters. TMT 6-plex (N-terminus and K) was used as quantification type, a 
quantification mass tolerance of 10 ppm was allowed and the threshold for peptide score was 
set at 20. In the quantification module of Peaks, global intensity normalization was performed 
to correct for unequal mixing of the TMT labeled samples. The expression patterns of 
clustered proteins are shown in a heatmap (Figure S1). The normalized log ratios of the 
reporter ion intensities were shown.  
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Results 
The identification and quantification of proteins extracted from formalin-fixed material is still 
a challenge. Although several research groups used label-free designs, label-based methods 
are often discarded in the context of FFPE proteomics 5, as most chemical labeling strategies 
tag amino acid residues which might be involved in crosslinking. However, using an isobaric 
labeling approach has several advantages including multiplexing and more precise 
quantification 13, because the sources of variation are constant for the multiplexed samples. 
Therefore, we extracted proteins from FFPE samples of three human colon carcinoma tissues 
and their paired healthy colon mucosa tissues and applied isobaric labeling. We used the 
direct tissue proteomics strategy, in which proteins of the whole FFPE slices were extracted. 
Although we removed paraffin using wash steps with xylene and ethanol graded series, some 
paraffin was still present in the samples, disturbing the LC analysis. However, by applying 1D 
gel electrophoresis, not only this excess of paraffin can be removed, also fractionation of the 
sample can be achieved. In spite of the popularity of the peptide labeling protocol, we choose 
protein labeling, as labeling and multiplexing the samples before 1D gel separation is more 
reproducible and less laborious than labeling samples after in-gel digestion. The resulting gel 
lane was subdivided into 3 gel fractions and analyzed separately using LC-MS/MS. For 
identification and quantification purposes, the three LC-MS/MS runs are combined in one 
data repository. 
Peptide and protein identification 
In FFPE proteomics research, several ‘unknown’ modifications can hamper the identification 
of proteins. In traditional database  search engines, like SEQUEST or MASCOT, the major 
drawback is that one needs to specify all the expected modifications (fixed and variable) 
before database searching is performed. Adding more dynamic modifications will 
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combinatorially increase the search space, which increases the number of chance findings. 
This drawback makes the database search strategy impractical for FFPE data. Using a 
combination of SEQUEST and MASCOT search engines, we could identify 79 proteins 
(FDR<5%) when applying standard settings including carbamidomethylation as fixed 
modification and TMT sixplex and oxidation at methionine as variable modification. Adding 
extra modifications, like phosphorylation (STY) or hydroxymethylation (K), did not provide 
substantially better results. A comparison between the different settings can be found in Table 
2.  
Because the database search strategy is suboptimal in the FFPE proteomic approach, we opted 
for an alternative identification strategy. In this case, the use of a de novo identification 
method increased the number of identifications as it accommodates unknown modifications in 
a flexible and robust manner. Consequently, Peaks 6 software was used to identify and 
quantify the FFPE extracted proteins. This software performs both de novo interpretation and 
database searching. Moreover, two extra modules: Peaks PTM and SPIDER, are of particular 
interest 14, 15. These modules are used to find modifications unforeseen for peptides which 
obtained a good de novo alignment, but which could not be identified by Peaks database 
searching. For example, in our preliminary dataset, de novo searches (average local 
confidence (ALC) ≥ 30%; tot al local confidence (TLC) ≥3)) resulted in 7943 peptides, from 
which 451 proteins could be identified using database searching. Our results were filtered 
such that proteins should have at least 1 unique peptide per protein identification and only 
confidently identified peptides (FDR<5%; peptide -10lgP ≥19,9) are included. In the Peaks 
PTM module, 396 high confident proteins were identified by following peptide identification 
settings (FDR<5%; peptide -10lgP ≥19) and Peaks Spider could identify 377 proteins (peptide 
FDR <5%, peptide -10lgP ≥18,9). In total, 713 unique proteins could be identified using the 
Peaks workflow. A detailed list of all protein identifications can be found in Table S1 in the 
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supplementary material. The identified proteins from the FFPE material were found to be part 
of a broad range of biological processes and arose from diverse cellular compartments. 
In comparison to standard database search engines, Peaks de novo sequencing algorithms 
delivers 6 times more high confident protein identifications and reaches even 10 times more 
identifications when including all the modules of Peaks. Furthermore, Peaks PTM gives a list 
of the most common post translational modifications that were found in our datasets. These 
modifications are summed in Table 3. Due to these extra modifications, higher protein 
coverage was achieved and up to 5% new confident protein accession numbers could be 
identified. From this list it can be observed that several post translational modifications 
(PTMs) take place at basic amino acids (K,R,H or N-term). Most likely, these modifications 
originate from formalin-induced crosslinking, which preferably is positioned at basic amino 
acids. Besides, the 5% newly identified proteins are found because a PTM was found in one 
of the unique peptides, which was missed and filtered out previously. Figure 1A shows a 
protein coverage view (IPI00010779;TPM4,isoform1) which is identified due to Peaks PTM. 
The figure gives an overview of all peptide matches found. Two unique peptides are present, 
and have unspecified modifications (acetylation and methylester). The fragmentation 
spectrum of one unique peptide is shown in Figure 1B. 
 
TMT protein labeling 
As the network of protein crosslinks might be different in each sample, we did establish the 
crosslink variability between six FFPE samples using Tandem Mass Tag (TMT) protein 
labeling. In the TMT approach, we receive for each identified peptide quantitative 
information regarding the sample  in which the peptide is found. These TMT isobaric tags 
consist out of an amine-reactive group, which reacts with N-terminal amine groups and the 
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epsilon-amine groups of lysine, a balancer group and a reporter ion group. In case of TMT, 
this reporter group has a different mass for each of the six variants of the TMT tags. 
Demultiplexing the pooled samples occurs in tandem MS mode where the isobaric tags will 
generate a reporter ion with a unique mass. The relative intensities of each unique reporter 
will give information about the relative abundance of the peptide in the pooled sample. 
Moreover, TMT sixplex has the capability to multiplex up to six different samples into one 
run, which reduces measurement time considerably. As most amine reactive amino acids 
regain their activity after heat induced extraction, isobaric tag labeling might be feasible in 
FFPE tissues. Moreover, the crosslink process is not necessarily the same in each sample and 
in each protein, and thus by multiplexing 6 samples into 1 run, the extraction efficiency and 
reversibility of the protein crosslinks can be evaluated, without differences in external 
experimental parameters of both LC and MS. 
To evaluate the protein labeling reaction, several factors were checked. First, the presence of 
TMT modifications in the identified proteins was examined. As these isobaric tags are 
reactive against free amine reactive groups, only peptides with lysine groups or N-terminal 
peptides will be labeled. TMT modification at lysine was found in 921 peptide to spectrum 
matches (PSM) for database searching. By extending the search using Peaks PTM, there were 
145 additional peptides found wherein lysine was modified by TMT. TMT sixplex 
modifications at the N-terminus, however, were present to a lesser extent in the identified 
proteins, which was expected when applying protein labeling. In total, 471 unique proteins 
were quantifiable. Secondly, the presence of the TMT reporter ions in the fragmentation 
spectra of the peptides were evaluated. The presence of 6 reporter ions indicates that the 
peptide is successfully extracted from six different FFPE samples. Figure 2 shows an example 
of a protein (IPI00216456, Histone H2A, type 1C) (Figure 2B) which contains several TMT 
sixplex modifications. In the corresponding fragmentation spectrum, the six reporter ions 
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were found (Figure 2A, 2C). In total, 1629 unique peptides were successfully extracted, 
identified and quantified in the six samples. Subsequently, the coefficient of variation (CV) 
values of the peptides extracted from control samples varies between 0,01 and 1,32. The CV 
values of tumor-extracted peptides ranges from 0,07 until 1,2. Third, protein labeling hinders 
the activity of trypsin at the lysine residue. As a result, the presence of tryptic peptides 
containing C-terminal lysine residues should be reduced. When looking at all the identified 
peptides, about 95% of the peptides are digested at arginine. These observations could also be 
the result of an extensive crosslinking at the lysine residue, however, most peptides containing 
lysines, also have TMT modifications. Forth, it is worth mentioning that 66% of the identified 
proteins using Peaks were also quantified in the six samples (Table S2).  All these factors 
prove that a good efficiency of TMT labeling can be confirmed.  
Furthermore, a quality control visualizing the different tumor vs. control ratios was performed 
using an MA-plot. In this plot, the log intensity ratios (M) of two TMT tags and their average 
log intensity (A) are plotted against each other for all the identified peptides. The general 
assumption concerning this plot is that most proteins will not show any change in expression, 
and should therefore be located around 0, since log (1) = 0. When any deviation is seen, 
further normalization is needed in order to obtain reliable results regarding quantification. 
Figure 3 shows the MA-plots of the different TMT pairs (tumor/control) for our TMT protein 
labeled samples. No abnormalities were seen in these plots, indicating that no interference 
between FFPE and TMT reporter ions was present. However, deviation from the ‘log(1)=0’ 
line is observed, which indicates that normalisation might be beneficial. Using the 
quantitation workflow of Peaks an auto-normalisation was carried out. Also, a clustering 
analysis on protein expression was performed to detect protein groups which behave similar 
across the control or tumor group. The resulting heatmap can be found in the Figure S1. As 
we used paired control and tumor samples, we looked for trends in which the reporter 
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intensities of the 127, 129 and 131 labeled samples have a higher/lower expression than their 
counterparts, respectively 126, 128 and 130. Several proteins did show a trend in upregulation 
in tumor samples compared to the paired healthy tissues. 
 
 
Discussion 
 
It is already known for several decades that FFPE tissue is a treasure for retrospective analysis 
concerning the amount of samples present in hospital archives, combined with pathological, 
clinical and outcome information available for every sample. In recent years, several research 
groups did show that protein extraction and identification is possible. Also, the challenges and 
pitfalls concerning FFPE proteomics have become clear 5. 
Unlocking the proteome of formalin-fixed tissues is still considered a challenge for two 
reasons: protein extraction might be hindered by crosslinks and protein identifications might 
be ambiguous due to possible unknown peptide modifications 16. In this study, we could show 
that hundreds of proteins can be efficiently extracted, identified and quantified from six FFPE 
samples which are processed and labeled (with isobaric tags) in parallel and multiplexed to 
one pool upon LC separation and mass spectrometry detection.  
In this study, we applied a combination of TMT protein labeling and 1D electrophoresis 
followed by LC-MS/MS (= GeLC-MS/MS). The application of 1D gel electrophoresis to 
FFPE extracted proteins has several advantages: not only will it fractionate the sample and 
thus reducing the complexity, it also has the possibility to visualize the high abundant 
proteins, which makes it possible to isolate these proteins from the less abundant ones, 
rendering more low abundant protein identifications. Moreover, the compatibility with most 
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FFPE extraction buffers is also major benefit. However, in GeLC-MS/MS label-free 
approaches, every sample needs to be fractionated and in-gel digested separately before LC-
MS/MS analysis is possible, leading to very laborious procedures which might be less 
reproducible. Therefore, isobaric labeling using TMT, which allows multiplexing up to six 
samples, might be a good alternative. These labels however, are mostly used in the context of 
peptide labeling. Performing TMT peptide labeling in combination with GeLC-MS/MS would 
even more complicate the workflow, as the in-gel digested protein fractions should be 
reduced, alkylated and labeled separately, before multiplexing is possible. All these additional 
sample handling steps will introduce a higher overall variability, certainly when working with 
smaller sample amounts. Therefore, labeling proteins rather than peptides has some major 
advances in the GeLC-MS/MS setup. The first advantage is that protein-based fractionation is 
less complex than a peptide-based procedure. Second, labeling of the proteins and 
multiplexing samples prior to in-gel digestion will benefit the reproducibility. Finally, this 
protein labeling strategy would also benefit FFPE analysis when using SDS PAGE as 
fractionation method, as paraffin, which might still be present in low amounts in the extracted 
protein samples, could otherwise contaminate the LC-run, leading to LC-results of low 
quality.  
In FFPE proteomics, it is known that the efficiency of protein recovery is influenced by the 
fixation protocol and the fixation time. FFPE tissues which are fixed in high concentrations of 
formalin (> 10%) or have long fixation times (> 72 hrs) will have a tighter network of 
molecular crosslinks 17. The archival time, on the other hand, has only limited influence on 
the protein extraction efficiency 18. In our study, samples were fixed in 6% formalin for 48 
hrs. Although the crosslinking process thus had the same time to expand, differences in the 
crosslink network between the different samples are likely to exist. Therefore, it might be 
possible that proteins are more easily extracted in one sample then in another, depending on 
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the crosslinks formed. To exclude the fact that proteins/peptides might, despite their efficient 
extraction, not be identified because of unknown or unpredicted modifications resulting from 
formalin fixation, paraffin embedding or the reversal of these processes, a comparison was 
made between standard database search engines like SEQUEST or MASCOT and de novo 
interpretation algorithms using Peaks software. A combination of these two standard search 
engines delivered only a limited amount of confident unique proteins, even when potential 
formalin-induced modifications were added in the search parameters.  In addition, to assess 
the influence of these degrees of freedom in the search parameters on the number of 
identifications, several different search parameter settings were tried, all generating these low 
numbers of identifications (Table 2). 
Because of the low identification rate using traditional database search engines, further 
elucidation of the MS/MS fragmentation spectra was performed using de novo interpretation 
of the data. The Peaks 6 software implements a combined de novo sequencing19, where 
tandem MS spectra are used to determine peptide sequences based on the obtained 
fragmentation pattern, and assisted database search for accurate peptide identification20. 
However, this de novo DB search does not support the identification of modified peptides to 
the most possible extent. To elucidate unknown modifications induced by formalin 
crosslinking, the Peaks PTM module was used. As opposed to traditional database search, 
where one can specify only a few well-defined modifications, this module considers all 
known 650 PTMs included in the Unimod database15. This way, unspecified modifications 
due to the crosslinking event can be elucidated with increasing FFPE protein and FFPE 
proteome coverage as a consequence. To achieve this goal, Peaks PTM includes database 
filters that allow to consider a rich set of PTMs for every peptide in the filtered database. This 
reduced database is the list of identified protein candidates proposed by MS/MS data 
interpretation using Peaks de novo and Peaks DB algorithms. From hereupon, an extensive 
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search to find peptides of the protein candidates with one (or more) PTM from the Unimod 
database can be performed15. As expected, several modifications, like acetylations and 
deamidations were found in the dataset. We noticed that high numbers of methionine 
oxidations were present. These could be linked to FFPE storage, as it is known that oxidation 
reactions are more pronounced in FFPE tissues and will only increase as the storage time of 
the archival samples will increase 18. Modifications which could be linked to the chemistry of 
formalin fixation might be (di)hydroxylations at basic amino acids and formylation which 
were present at lysine and, N-termini as well as at other amino acids. These can be the result 
from the breakdown of the methylene bridges during heat induced protein extraction. 
However, FFPE modifications predicted in model peptides, like hydroxymethyl (methylol) 
groups were not found in real biological samples, although present in the Unimod database. 
These findings only emphasize that formalin-based crosslinking has a high degree of 
complexity and that the samples are probably even more heterogeneous than can be assessed 
by mass spectrometry 16. This could also explain why a comparison between the proteome of 
frozen and FFPE tissue only overlapped for 40%-90% 21.  In total, we could identify 713 
confident unique proteins using Peaks, which is almost 10 times more than using standard 
search engines. This emphasizes that Peaks software is a valuable alternative for identification 
purposes. Moreover, this approach differs from other bioinformatic identification tools 
dealing with crosslinked peptides 13, 22. 
Although identification of several formalin-induced modifications on peptides is possible now 
using Peaks software, the question remains whether it is possible to extract proteins from 
FFPE samples in a reproducible way. As far as is understood these days, formalin fixation 
leads to chemical crosslinks of RNA, DNA and proteins and affects proteins at different 
levels. First of all, the modification of amino acid residues modifies the primary structure. 
Metz and colleagues performed experiments on the reaction of formaldehyde with insulin as a 
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model protein, and showed that several amino acids (arginine, asparagine, histidine, 
glutamine, tryptophan and tyrosine) could react with unstable adducts from the formaldehyde 
reaction. The position and local environment of each reactive amino acid however, did affect 
the reactivity23. So, in general, each protein in each sample will not have exactly the same 
environment, possibly leading to variation in modifications and crosslink formation between 
proteins, DNA and RNA. The variation might be even more extensive when one thinks about 
the reversal of the protein-induced crosslinks upon protein extraction. Moreover, crosslinking 
also involves changes in secondary, tertiary and quaternary structures, including the formation 
of complexes that are hard to unravel by mass spectrometry16.  
To elucidate whether it is even possible to extract the same peptides from 6 different samples, 
we applied TMT labeling to FFPE extracted proteins. By multiplexing these 6 samples into 1 
run, before sample processing was performed, all other technical factors could be ruled out.  
The use of TMT labeling as quantification method might seem a challenge in FFPE tissue. 
We could show that although modifications of lysine and N-termini exists in FFPE tissue, 
TMT technology showed good performance, as the reporter ions of hundreds of FFPE 
extracted proteins were found. In this study, we labeled proteins extracted from six different 
FFPE samples with six different isobaric TMT tags to evaluate the variation in protein 
extraction and digestion. We could successfully identify and quantify 1629 unique peptides in 
which the six TMT reporter ratios are present. This indicates that, although the crosslink 
network might be different in each sample, proteins can efficiently be extracted in these 6 
samples using our procedure. A further look at the CV values of the TMT reporter ion 
intensities showed us that, even though the quantification is successful, several peptides did 
show CV values above 1. These observations are important for future quantitative proteomics 
experiments, as more biological replicates will be necessary per experimental group 
(compared to fresh frozen material) in order to achieve statistically significant results. 
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Determination of both within and between experimental group variations do also show that 
the FFPE crosslink ‘background’ is the same for both groups, indicating that biological 
differences can be observed in FFPE context. Other research groups also used isobaric 
labeling in formalin-fixed tissues to quantify proteins by applying peptide labeling 11, 12 
instead of protein labeling 24. In this study, we showed that protein labeling can be regarded as 
a valid alternative and that it also simplifies the labeling protocol in a GeLC-MS/MS setup. 
Applying isobaric labeling has the advantage that more accurate quantifications can be 
achieved than in label free (e.g. spectral counting) approaches because it provides information 
about the six samples simultaneously in one LC and MS run. Also, in the fragmentation 
spectra, the reporter ions are in a noise-free region of the spectrum which enhances 
quantification. Moreover, the use of HCD as a second fragmentation method, can ensure that 
a good quantification can be obtained. Finally, the ability to multiplex up to six samples in 
one run, has the advantage to save mass spectrometry measurement time. A disadvantage, on 
the other hand, is that only N-terminal peptides and peptides containing lysine residues are 
quantifiable. 
In the quantification workflow of peaks, hierarchal clustering of normalized quantified 
proteins was performed (Figure S1). As noticed, patient 1 has lower intensity values for 
almost all proteins. The protein ratios per patient (127/126 = patient 1, 129/128 = patient 2, 
131/130 = patient 3) do show a trend of upregulation of several proteins in colon tumors 
(Figure S1). Some of them have structural functions (Collagen 4 A2, Histone H2A), some 
others had functions related with the cancer process: Enolase 1 is involved in the regulation of 
transcription; Mast cell tryptase beta III on the other hand, is important in the inflammatory 
process. Moreover, it is known that cancer associated inflammation is an important trigger 
which promotes cancer progression and metastasis 25. However, since we are just using a 
limited number of non-standardized samples, no biomarker candidates will be proposed. First, 
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although all patients had non-metastatic colorectal cancer, further distinction between the 
cancer types is necessary for biomarker experiments in order to find cancer-stage related 
differences. Secondly, more biological replicates are needed before any conclusions regarding 
biomarker candidates can be drawn. Also, using FFPE tissues for biomarker discovery will 
need more biological replicates compared to fresh or frozen tissues, as the crosslinking event 
is adding extra technical variation. Finally, further statistical improvements of the Peaks 
quantification workflow are needed in order to draw conclusions concerning TMT reporter 
ratios. We want to show, however, that using Peaks software for peptide identification (and 
quantification) purposes will benefit the FFPE proteome elucidation. 
In conclusion, the data reported here show that hundreds of proteins extracted from diverse 
FFPE tissues could be successfully identified and quantified, despite the variability of the 
crosslink networks in different samples. The setup using GeLC-MS/MS in combination with 
TMT protein labeling and de novo sequencing algorithms delivers thus reproducible results. 
However, it should also be mentioned that the event of crosslinking due to formaldehyde is 
not completely understood, but that software packages, like Peaks including Peaks PTM are a 
first step in characterizing unexpected peptide modifications. However, further research 
concerning the crosslink event is  necessary in order to obtain a more complete protein and 
proteome coverage.  
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Tables 
Table 1: Information on the paired colon mucosa samples used in the labeling experiment 
 
Table 2:  Overview of search parameters and identifications using standard search 
engines 
 
 
Table 3: Overview of PTM profile of FFPE samples using PeaksPTM 
Name Δ Mass (Da) # PSM Position 
TMT6-plex 229,16 1066 K,N-term 
Oxidation 15,99 367 M 
Hydroxylation 15,99 279 DKPR 
Dihydroxy 31,99 166 FKPRW 
Deamidation 0,98 105 NQ 
Carbamidomethylation 57,02 104 C 
Acetylation 42,01 71 N-term 
Acetylation 42,01 58 Protein N-term 
Methyl ester 14,02 37 DE,C-term 
Settings Samples Fixed Modifications Variable Modifications  # peptides # proteins
1 total of GeLC repository carbamidomethyl ( C) TMT (N-term, K) +Oxidation (M) 211 79
2 total of GeLC repository carbamidomethyl ( C) TMT (N-term, K) +Oxidation (M)+ phospho (STY) 205 83
3 total of GeLC repository carbamidomethyl ( C) TMT (N-term, K) +Oxidation (M)+ acetyl (K, N-term) 205 83
4 total of GeLC repository carbamidomethyl ( C) TMT (N-term, K) +Oxidation (M)+ hydroxymethyl (K) 218 84
5 total of GeLC repository carbamidomethyl ( C) TMT (N-term, K) +Oxidation (M)+ methyl (K) 221 80
Settings Samples  # peptides mascot (medium)  # peptides mascot (high) FDR medium mascot FDR high mas # peptides s   # peptides sequest (high) FDR medium sequest FDR high sequest
1 FFPE_GeLC_Fraction1 174 86 0.0460 0.0000 120 88 0.0417 0.0000
FFPE_GeLC_Fraction2 122 75 0.0492 0.0000 101 96 0.0297 0.0000
FFPE_GeLC_Fraction3 98 48 0.0408 0.0000 71 56 0.0282 0.0000
2 FFPE_GeLC_Fraction1 145 78 0.0483 0.0000 99 83 0.0303 0.0000
FFPE_GeLC_Fraction2 93 55 0.0430 0.0000 70 60 0.0286 0.0000
FFPE_GeLC_Fraction3 89 45 0.0449 0.0000 46 44 0.0217 0.0000
3 FFPE_GeLC_Fraction1 133 87 0.0451 0.0000 128 70 0.0469 0.0000
FFPE_GeLC_Fraction2 101 73 0.0495 0.0000 98 87 0.0306 0.0000
FFPE_GeLC_Fraction3 86 54 0.0465 0.0000 75 60 0.0400 0.0000
4 FFPE_GeLC_Fraction1 98 48 0.0408 0.0000 74 55 0.0405 0.0000
FFPE_GeLC_Fraction2 122 75 0.0492 0.0000 105 99 0.0286 0.0000
FFPE_GeLC_Fraction3 174 86 0.0460 0.0000 117 88 0.0342 0.0000
5 FFPE_GeLC_Fraction1 180 102 0.0500 0.0098 124 84 0.0323 0.0000
FFPE_GeLC_Fraction2 108 72 0.0463 0.0000 96 89 0.0208 0.0000
FFPE_GeLC_Fraction3 109 48 0.0459 0.0000 57 54 0.0351 0.0000
Healthy tissue Cancer tissue 
Sample Labeling tag Sample Cancer stage Labeling tag 
Sample 1a TMT 126 Sample 1b T4N0 TMT 127 
Sample 2a TMT 128 Sample 2b T1N0 TMT 129 
Sample 3a TMT 130 Sample 3b T2N1 TMT 131 
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Deoxy -15,99 31 T 
Cation:Fe 53,92 28 DE  
Acetylation 42,01 26 K  
Dehydration -18,01 21 DST 
Carbamidomethyl 57,02 11 DEHK,N-term 
Sulfone 31,99 11 M 
Formylation 27,99 11 K,N-term 
TMT  224,15 8 N-term 
Formylation 27,99 7 Protein N-term 
Didehydro -2,02 6 T,C-term 
Oxidation 15,99 5 W 
 
Figure Legends 
Figure 1: Identification and quantification of proteins 
Using PeaksPTM, several unspecified modifications were found. Panel A shows the sequence 
coverage of tropomyosin 4, isoform 1, in which two modifications were found in two unique peptides 
which made it possible to confidently identify this protein. Panel B shows a fragmentation spectrum of 
a unique protein.  
 
 
 
Figure 2:  Fragmentation spectra with six reporter ions 
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In panel B, the sequence coverage of histone H2A, type 1C is shown. Several peptides have TMT 
modifications, pointing out that the TMT labeling was efficient. Moreover, in their corresponding 
fragmentation spectra (panel A), all six reporters ions were found, which makes quantification 
feasible.  Panel C shows some high energy collision dissociation spectra, in which the efficiency of 
reporter ion formation is higher.  
 
 
 
 
Figure 3: Quality control of TMT protein labeling 
The MA-plots of the different paired tumor versus control samples (127/126, 129/128 and 131/130) 
are shown. Although the center of the ‘cloud’ should be found around 0, assuming that most peptides 
are not differentially expressed, several deviations can be seen, which means normalisation has to be 
performed.  
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Supplemental data 
Table S1: Overview of all identified proteins found in the ACN dataset. All identified proteins contain 
at least one unique peptide and the overall protein score (-10logP) must be higher than 20 (FDR< 5%) 
to be selected as a confident identification.  
Table S2 : Overview of all quantified proteins found in the ACN dataset. In order to be selected as 
quantified protein, reporter intensities of each of the six reporter ions should be available.  
Figure S1: Heatmap of quantified proteins. Trends in upregulation of tumor samples (TMT 
127,129,131) can be seen compared to control colon mucosa (TMT 126,128,130. 
 
